4//SEC Filing
Ratcliffe Liam 4
Accession 0000899243-21-044697
CIK 0001655759other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 9:45 PM ET
Size
32.3 KB
Accession
0000899243-21-044697
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Ratcliffe Liam
Director
Transactions
- Sale
Common Stock
2021-11-10$90.18/sh−1,852$167,013→ 673,849 total(indirect: See footnote) - Sale
Common Stock
2021-11-10$87.11/sh−3,956$344,624→ 662,542 total(indirect: See footnote) - Sale
Common Stock
2021-11-11$87.71/sh−5,582$489,591→ 656,761 total(indirect: See footnote) - Sale
Common Stock
2021-11-11$85.92/sh−36,210$3,111,333→ 602,544 total(indirect: See footnote) - Sale
Common Stock
2021-11-10$89.16/sh−1,498$133,560→ 672,351 total(indirect: See footnote) - Sale
Common Stock
2021-11-10$88.12/sh−5,853$515,760→ 666,498 total(indirect: See footnote) - Sale
Common Stock
2021-11-10$86.59/sh−199$17,231→ 662,343 total(indirect: See footnote) - Sale
Common Stock
2021-11-11$86.38/sh−18,007$1,555,468→ 638,754 total(indirect: See footnote) - Sale
Common Stock
2021-11-12$84.31/sh−9,660$814,474→ 575,435 total(indirect: See footnote) - Sale
Common Stock
2021-11-12$84.02/sh−12,760$1,072,100→ 562,675 total(indirect: See footnote) - Sale
Common Stock
2021-11-12$85.96/sh−17,449$1,499,886→ 585,095 total(indirect: See footnote) - Sale
Common Stock
2021-11-15$85.07/sh−17,752$1,510,122→ 544,923 total(indirect: See footnote) - Sale
Common Stock
2021-11-15$83.90/sh−3,532$296,347→ 541,391 total(indirect: See footnote)
Footnotes (14)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.75 to $90.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.15 to $86.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (10).
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.14 to $85.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (11).
- [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.115, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (12).
- [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.57 to $85.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (13).
- [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (14).
- [F2]The reported shares are held directly by AI Biotechnology LLC ("AIB"), a limited liability company of which the reporting person is the holder of units that are treated as profits interest units. The units owned by the reporting person do not convey a right to vote or dispose of the shares of the Issuer's Common Stock held by AIB. The reporting person disclaims beneficial ownership of all shares held by AIB and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.68 to $89.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.66 to $88.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.65 to $87.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5).
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.57 to $86.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6).
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.07 to $88.065, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (7).
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.06 to $87.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (8).
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.25 to $86.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9).
Documents
Issuer
ARVINAS, INC.
CIK 0001655759
Entity typeother
Related Parties
1- filerCIK 0001547100
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 9:45 PM ET
- Size
- 32.3 KB